TrialInvestigational new drugs2018
Phase II study of doxorubicin and thalidomide in patients with refractory aggressive fibromatosis.
Xin Liu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papertrialcites it
TrialInvestigational new drugs2018
Xin Liu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.